ATG versus alemtuzumab in allogeneic stem cell transplantation: a systematic review and meta-analysi

来源 :中华医学会血液学分会第九次全国造血干细胞移植学术会议 | 被引量 : 0次 | 上传用户:Yxiaowanzi
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 To perform a meta-analysis of all studies comparing Antithymocyte globulin (ATG) and alemtuzumab or graft-versus-host disease (GVHD) prophylaxis in allogeneic haematopoietic stem cell transplantation and to evaluate their benefits and drawbacks.
其他文献
目的 评价自体造血干细胞移植(APBSCT)治疗多发性骨髓瘤(MM)的临床疗效.方法 回顾性分析我院11例ISS分期为Ⅰ~Ⅲ期的接受化疗联合APBSCT治疗的多发性骨髓瘤患者.11例患者移植前给予常规联合化疗(5例含万珂),采用大剂量环磷酰胺(HD-CTX)联合粒细胞集落刺激因子(G-CSF)方案动员干细胞,选择以马法兰为基础的预处理方案,(其中6例患者在马法兰基础上加用硼替佐米),随访分析移植后
会议
目的 To observe the effects of HBV infection on the hematopoietic stem cell collection and implantation of lymphoma patients received APHSCT.
会议
目的 探讨原发性骨淋巴瘤(primary bone lymphoma,PBL)的临床特征、诊断、治疗及预后.方法 回顾分析1例PBL患者的临床资料并结合文献进行复习.结果患者表现为颈肩部及胸骨疼痛,左上肢尺侧麻木,发热,盗汗,消瘦.
会议
目的 Acute graft-versus-host disease (aGVHD) remains a significant cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation recipients.Additionally, it is unclear which tre
会议
目的 在完整家系中研究不同KIR单体型对单倍体造血干细胞移植(HSCT)预后的影响.方法 156个完整家系包括父母和子女共计468个样本,采用SSP方法进行17种已知KIR基因分型.其中92例患者接受了亲缘单倍体HSCT,包括AML/MDS31例,ALL/NHL45例,CML4例,其他血液病12例.
会议
目的 Introduction: Mesenchymal stem cells (MSCs) contribute to the engraftment of transplanted hemato-poietic stem cells (HSCs).
会议
目的 Background and Objective: Cyclosporine A (CsA) has been used as immunosuppressive therapy after allogeneic hematopoietic stem cell transplantation (HSCT) for about 30 years.
会议
目的 Objectives: To compare the effects of the use of alloSCT from a matched sibling donor which includes single alloSCT, non-myeloablative alloSCT and prior ASCT followed by non-myeloablative alloSCT f
会议
目的 This review discusses recent insights into the role, mechanism, clinical applications, differences and the fundamental interactions of G-CSF and AMD3100 in stem cell mobilisation and chemotherapy f
会议
目的 The detection of fetal liver tyrosine kinase 3 (FLT3) internal tandem duplications (ITDs) has been used as a powerful adverse prognostic indicator for acute myeloid leukemia (AML) in any age group.
会议